| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 7673 | 2021 |
| EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection European Association For The Study Of The Liver Journal of hepatology 67 (2), 370-398, 2017 | 2302 | 2017 |
| Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques F Tacke, D Alvarez, TJ Kaplan, C Jakubzick, R Spanbroek, J Llodra, ... The Journal of clinical investigation 117 (1), 185-194, 2007 | 1313 | 2007 |
| Langerhans cells arise from monocytes in vivo F Ginhoux, F Tacke, V Angeli, M Bogunovic, M Loubeau, XM Dai, ... Nature immunology 7 (3), 265-273, 2006 | 800 | 2006 |
| Micro‐RNA profiling reveals a role for miR‐29 in human and murine liver fibrosis C Roderburg, GW Urban, K Bettermann, M Vucur, H Zimmermann, ... Hepatology 53 (1), 209-218, 2011 | 777 | 2011 |
| Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts JC Ochando, C Homma, Y Yang, A Hidalgo, A Garin, F Tacke, V Angeli, ... Nature immunology 7 (6), 652-662, 2006 | 705 | 2006 |
| Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis KR Karlmark, R Weiskirchen, HW Zimmermann, N Gassler, F Ginhoux, ... Hepatology 50 (1), 261-274, 2009 | 665 | 2009 |
| Comparison of gene expression profiles between human and mouse monocyte subsets MA Ingersoll, R Spanbroek, C Lottaz, EL Gautier, M Frankenberger, ... Blood, The Journal of the American Society of Hematology 115 (3), e10-e19, 2010 | 662 | 2010 |
| Migratory fate and differentiation of blood monocyte subsets F Tacke, GJ Randolph Immunobiology 211 (6-8), 609-618, 2006 | 623 | 2006 |
| Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study D Razavi-Shearer, I Gamkrelidze, MH Nguyen, DS Chen, P Van Damme, ... The lancet Gastroenterology & hepatology 3 (6), 383-403, 2018 | 622 | 2018 |
| Macrophage heterogeneity in liver injury and fibrosis F Tacke, HW Zimmermann Journal of hepatology 60 (5), 1090-1096, 2014 | 601 | 2014 |
| Liver macrophages in tissue homeostasis and disease O Krenkel, F Tacke Nature Reviews Immunology 17 (5), 306-321, 2017 | 533 | 2017 |
| Immunology in the liver—from homeostasis to disease F Heymann, F Tacke Nature reviews Gastroenterology & hepatology 13 (2), 88-110, 2016 | 523 | 2016 |
| Roles for chemokines in liver disease F Marra, F Tacke Gastroenterology 147 (3), 577-594. e1, 2014 | 522 | 2014 |
| Modeling nafld disease burden in china, france, germany, italy, japan, spain, united kingdom, and united states for the period 2016–2030 C Estes, QM Anstee, MT Arias-Loste, H Bantel, S Bellentani, J Caballeria, ... Journal of hepatology 69 (4), 896-904, 2018 | 481 | 2018 |
| Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis A Zernecke, I Bot, Y Djalali-Talab, E Shagdarsuren, K Bidzhekov, S Meiler, ... Circulation research 102 (2), 209-217, 2008 | 460 | 2008 |
| Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis Z Younossi, F Tacke, M Arrese, B Chander Sharma, I Mostafa, ... Hepatology 69 (6), 2672-2682, 2019 | 459 | 2019 |
| Targeting hepatic macrophages to treat liver diseases F Tacke Journal of hepatology 66 (6), 1300-1312, 2017 | 422 | 2017 |
| A randomized, placebo‐controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis SL Friedman, V Ratziu, SA Harrison, MF Abdelmalek, GP Aithal, ... Hepatology 67 (5), 1754-1767, 2018 | 421 | 2018 |
| Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury C Baeck, A Wehr, KR Karlmark, F Heymann, M Vucur, N Gassler, S Huss, ... Gut 61 (3), 416-426, 2012 | 408 | 2012 |
